Canada
· Delayed Price · Currency is CAD Burcon NutraScience Statistics
Total Valuation
Burcon NutraScience has a market cap or net worth of 34.10 million. The enterprise value is 36.57 million.
| Market Cap | 34.10M |
| Enterprise Value | 36.57M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Burcon NutraScience has 142.09 million shares outstanding. The number of shares has increased by 30.68% in one year.
| Shares Outstanding | 142.09M |
| Shares Change (YoY) | +30.68% |
| Shares Change (QoQ) | +16.76% |
| Owned by Insiders (%) | 25.83% |
| Owned by Institutions (%) | 0.26% |
| Float | 103.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 454.55 |
| PS Ratio | 184.98 |
| PB Ratio | 6.62 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 198.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.83, with a Debt / Equity ratio of 1.29.
| Current Ratio | 3.83 |
| Quick Ratio | 3.54 |
| Debt / Equity | 1.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.59 |
Financial Efficiency
Return on equity (ROE) is -144.49% and return on invested capital (ROIC) is -63.23%.
| Return on Equity (ROE) | -144.49% |
| Return on Assets (ROA) | -57.67% |
| Return on Capital (ROIC) | -63.23% |
| Revenue Per Employee | 7,374 |
| Profits Per Employee | -297,848 |
| Employee Count | 25 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 12.58 |
Taxes
In the past 12 months, Burcon NutraScience has paid 130,966 in taxes.
| Income Tax | 130,966 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.57% in the last 52 weeks. The beta is 2.97, so Burcon NutraScience's price volatility has been higher than the market average.
| Beta (5Y) | 2.97 |
| 52-Week Price Change | +53.57% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.20 |
| Relative Strength Index (RSI) | 36.77 |
| Average Volume (20 Days) | 24,259 |
Short Selling Information
The latest short interest is 130,577, so 0.09% of the outstanding shares have been sold short.
| Short Interest | 130,577 |
| Short Previous Month | 115,455 |
| Short % of Shares Out | 0.09% |
| Short % of Float | 0.13% |
| Short Ratio (days to cover) | 5.32 |
Income Statement
In the last 12 months, Burcon NutraScience had revenue of 184,359 and -7.45 million in losses. Loss per share was -0.06.
| Revenue | 184,359 |
| Gross Profit | -352,808 |
| Operating Income | -7.47M |
| Pretax Income | -7.45M |
| Net Income | -7.45M |
| EBITDA | -6.74M |
| EBIT | -7.45M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 4.20 million in cash and 6.67 million in debt, giving a net cash position of -2.47 million or -0.02 per share.
| Cash & Cash Equivalents | 4.20M |
| Total Debt | 6.67M |
| Net Cash | -2.47M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | 5.15M |
| Book Value Per Share | 0.04 |
| Working Capital | 3.83M |
Cash Flow
In the last 12 months, operating cash flow was -5.72 million and capital expenditures -127,114, giving a free cash flow of -5.84 million.
| Operating Cash Flow | -5.72M |
| Capital Expenditures | -127,114 |
| Free Cash Flow | -5.84M |
| FCF Per Share | -0.04 |
Margins
Gross margin is -191.37%, with operating and profit margins of -4,053.41% and -4,038.96%.
| Gross Margin | -191.37% |
| Operating Margin | -4,053.41% |
| Pretax Margin | -4,038.96% |
| Profit Margin | -4,038.96% |
| EBITDA Margin | -3,658.44% |
| EBIT Margin | -4,038.56% |
| FCF Margin | -3,169.74% |
Dividends & Yields
Burcon NutraScience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.68% |
| Shareholder Yield | -30.68% |
| Earnings Yield | -21.83% |
| FCF Yield | -17.14% |
Analyst Forecast
| Price Target | 1.85 |
| Price Target Difference | 670.83% |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 29, 2019. It was a forward split with a ratio of 153:94.
| Last Split Date | May 29, 2019 |
| Split Type | Forward |
| Split Ratio | 153:94 |